These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 12910678)
1. [Optimizing cultural conditions of measles vaccine working seed lot with orthogonal experiments]. Chen T; Chen P; Jia W; Liu Y; Jiang R; Peng W; Shi D Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):421-3. PubMed ID: 12910678 [TBL] [Abstract][Full Text] [Related]
2. Sorbitol-gelatin and glutamic acid-lactose solutions for stabilization of reference preparations of measles virus. de Rizzo E; Tenório EC; Mendes IF; Fang FL; Pral MM; Takata CS; Miyaki C; Gallina NM; Tuchiya HN; Akimura OK Bull Pan Am Health Organ; 1989; 23(3):299-305. PubMed ID: 2571379 [TBL] [Abstract][Full Text] [Related]
3. Clinical and immunologic observations on two lines of attenuated measles vaccine virus upon passage in chick embryo cell culture. Chun H; T'eh-chang H; Kuo-hua T; Shou-teh C; Wen-huan W; Chi-ming C; Yu-fen K; Chü-yeh Y; Lan H Chin Med J (Engl); 1975 Jul; 1(4):283-6. PubMed ID: 810334 [No Abstract] [Full Text] [Related]
4. Use of human diploid cell MRC-5, for production of measles and rubella virus vaccines. Mirchamsy H; Shafyi A; Bahrami S; Kamali M; Nazari P Dev Biol Stand; 1976 Dec 13-15; 37():297-300. PubMed ID: 1031692 [TBL] [Abstract][Full Text] [Related]
5. Studies on the modification of the live AIK measles vaccine. I. Adaptation of the further attenuated AIK measles virus (the strain AIK-L33) to chick embryo cells. Sasaki K Kitasato Arch Exp Med; 1974 Jun; 47(1-2):1-12. PubMed ID: 4217404 [No Abstract] [Full Text] [Related]
6. Production of yellow fever 17DD vaccine virus in primary culture of chicken embryo fibroblasts: yields, thermo and genetic stability, attenuation and immunogenicity. Freire MS; Mann GF; Marchevsky RS; Yamamura AM; Almeida LF; Jabor AV; Malachias JM; Coutinho ES; Galler R Vaccine; 2005 Mar; 23(19):2501-12. PubMed ID: 15752837 [TBL] [Abstract][Full Text] [Related]
7. Attenuation and characterisation of Edmonston-Zagreb measles virus. Ikić D; Juzbasić M; Beck M; Hrabar A; Cimbur-Schreiber T Ann Immunol Hung; 1972; 16(0):175-81. PubMed ID: 4679646 [No Abstract] [Full Text] [Related]
8. Molecular and phenotypic analysis of a working seed lot of yellow fever virus 17DD vaccine strain produced from the secondary seed lot 102/84 with an additional passage in chicken embryos. Marchevsky RS; da Luz Leal M; Homma A; Coutinho ES; Camacho LA; Jabor AV; Galler R; Freire MS Biologicals; 2006 Sep; 34(3):191-7. PubMed ID: 16326110 [TBL] [Abstract][Full Text] [Related]
9. [Analysis and evaluation on quality of live attenuated measles vaccine from market surveillance sampling]. Fang HH; Wang XX; Yi M Zhongguo Yi Miao He Mian Yi; 2009 Dec; 15(6):511-5. PubMed ID: 20518326 [TBL] [Abstract][Full Text] [Related]
10. Experimental studies on attenuated measles virus. Zahorska R; Mazur N Acta Microbiol Pol A; 1973; 5(3):251-8. PubMed ID: 4203634 [No Abstract] [Full Text] [Related]
11. [Clinical and immunologic observation on 2 lines of attenuated measles vaccine virus on passage in chick embryo tissue culture]. Chun H; Tsu TC; Tseng KH; Chang ST; Wu WH Zhonghua Yi Xue Za Zhi; 1973 Nov; 11():661-3. PubMed ID: 4203046 [No Abstract] [Full Text] [Related]
12. [Titration and stability tests for antimeasles vaccine]. Ayala-González M Bol Med Hosp Infant Mex; 1990 Jul; 47(7):512-5. PubMed ID: 2206418 [TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of vaccine strains of measles virus in suckling hamsters. Mirchamsy H; Razavi J; Ahurai P Acta Virol; 1972 Jun; 16(1):77-9. PubMed ID: 4400679 [No Abstract] [Full Text] [Related]
14. Determination of the coding and non-coding nucleotide sequences of genuine Edmonston-Zagreb master seed and current working seed lot. Baricević M; Forcić D; Gulija TK; Jug R; Mazuran R Vaccine; 2005 Jan; 23(8):1072-8. PubMed ID: 15620481 [TBL] [Abstract][Full Text] [Related]
15. On the importance of the s marker in differentiation of attenuated and non-attenuated strains of measles virus. Khozinsky VI; Seybil VB; Panteleyeva NS; Shapovalova SM Acta Virol; 1967 Sep; 11(5):432-5. PubMed ID: 4383026 [No Abstract] [Full Text] [Related]
16. Approaches to attenuation of an autochthonous measles virus strain. Cernescu C; Cajal N; Cepleanu M; Sorodoc Y Rev Roum Virol (1972); 1973; 10(2):117-26. PubMed ID: 4724473 [No Abstract] [Full Text] [Related]
17. Measles virus mutants and their implications in basic and applied virology. Makino S Ann Microbiol (Paris); 1977; 128B(4):507-15. PubMed ID: 565182 [No Abstract] [Full Text] [Related]
19. Development of a measles vaccine production process in MRC-5 cells grown on Cytodex1 microcarriers and in a stirred bioreactor. Trabelsi K; Majoul S; Rourou S; Kallel H Appl Microbiol Biotechnol; 2012 Feb; 93(3):1031-40. PubMed ID: 21935589 [TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age. Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM; Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]